Global Phage Therapy Competitive Landscape Professional Research Report 2024
Research Summary
Phage therapy is a form of medical treatment that utilizes bacteriophages, which are viruses that infect and kill bacteria, to combat bacterial infections in humans or animals. Bacteriophages are highly specific to particular strains of bacteria, allowing for targeted and precise treatment. In phage therapy, specific phages are selected to match the infectious bacteria, and these phages are then administered to the patient, typically in the form of a phage cocktail. The phages infect and replicate within the bacterial cells, ultimately leading to the destruction of the bacteria. Phage therapy has been explored as an alternative or complementary approach to antibiotics, particularly in cases where antibiotic resistance poses a challenge. While phage therapy has shown promise, it is still an evolving field, and further research is needed to establish its safety and efficacy for widespread clinical use.
According to DIResearch's in-depth investigation and research, the global Phage Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Phage Therapy include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences, Pharmex Group, Pherecydes Pharma, APS Biocontrol, Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, MicroMir, iNtODEWORLD, NEXTBIOTICS, Armata Pharmaceuticals, Innophage, Adaptive Phage Therapeutics, TechnoPhage etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Phage Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Phage Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Phage Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phage Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Phage Therapy Include:
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences
Pharmex Group
Pherecydes Pharma
APS Biocontrol
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International
MicroMir
iNtODEWORLD
NEXTBIOTICS
Armata Pharmaceuticals
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Phage Therapy Product Segment Include:
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Phage Therapy Product Application Include:
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Phage Therapy Industry PESTEL Analysis
Chapter 3: Global Phage Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Phage Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Phage Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Phage Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources